P.A.W. Capital’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $295K | Sell |
|
|||||
|
2022
Q3 | $4.07M | Hold |
|
|||||
|
2022
Q2 | $3.4M | Hold |
|
|||||
|
2022
Q1 | $4.48M | Buy |
|
|||||
|
2021
Q4 | $2.6M | Buy |
|
|||||
|
2021
Q3 | $2.67M | Hold |
|
|||||
|
2021
Q2 | $3.41M | Buy |
|
|||||
|
2021
Q1 | $3.36M | Sell |
|
|||||
|
2020
Q4 | $4.92M | Buy |
|
|||||
|
2020
Q3 | $2.93M | Buy |
|
|||||
|
2020
Q2 | $2.88M | Sell |
|
|||||
|
2020
Q1 | $2.45M | Buy |
|
|||||
|
2019
Q4 | $2.15M | Sell |
|
|||||
|
2019
Q3 | $2.05M | Hold |
|
|||||
|
2019
Q2 | $2.12M | Buy |
|
|||||
|
2019
Q1 | $2.66M | Sell |
|
|||||
|
2018
Q4 | $2.23M | Buy |
|
|||||
|
2018
Q3 | $420K | Sell |
|
|||||
|
2018
Q2 | $1.1M | Sell |
|
|||||
|
2018
Q1 | $1.33M | Buy |
|
|||||
|
2017
Q4 | $1.4M | Buy |
|
|||||
|
2017
Q3 | $880K | Buy |
|